472 related articles for article (PubMed ID: 26470616)
1. Pain management in patients with hidradenitis suppurativa.
Horváth B; Janse IC; Sibbald GR
J Am Acad Dermatol; 2015 Nov; 73(5 Suppl 1):S47-51. PubMed ID: 26470616
[TBL] [Abstract][Full Text] [Related]
2. Treatment of hidradenitis supprurativa associated pain with nonsteroidal anti-inflammatory drugs, acetaminophen, celecoxib, gabapentin, pegabalin, duloxetine, and venlafaxine.
Scheinfeld N
Dermatol Online J; 2013 Nov; 19(11):20616. PubMed ID: 24314785
[TBL] [Abstract][Full Text] [Related]
3. Hidradenitis suppurativa in the pediatric population.
Liy-Wong C; Pope E; Lara-Corrales I
J Am Acad Dermatol; 2015 Nov; 73(5 Suppl 1):S36-41. PubMed ID: 26470613
[TBL] [Abstract][Full Text] [Related]
4. Combination of oral zinc gluconate and topical triclosan: An anti-inflammatory treatment modality for initial hidradenitis suppurativa.
Hessam S; Sand M; Meier NM; Gambichler T; Scholl L; Bechara FG
J Dermatol Sci; 2016 Nov; 84(2):197-202. PubMed ID: 27554338
[TBL] [Abstract][Full Text] [Related]
5. Assessing the validity, responsiveness and meaningfulness of the Hidradenitis Suppurativa Clinical Response (HiSCR) as the clinical endpoint for hidradenitis suppurativa treatment.
Kimball AB; Jemec GB; Yang M; Kageleiry A; Signorovitch JE; Okun MM; Gu Y; Wang K; Mulani P; Sundaram M
Br J Dermatol; 2014 Dec; 171(6):1434-42. PubMed ID: 25040429
[TBL] [Abstract][Full Text] [Related]
6. Local wound care and topical management of hidradenitis suppurativa.
Alavi A; Kirsner RS
J Am Acad Dermatol; 2015 Nov; 73(5 Suppl 1):S55-61. PubMed ID: 26470618
[TBL] [Abstract][Full Text] [Related]
7. Resorcinol peels as a possible self-treatment of painful nodules in hidradenitis suppurativa.
Boer J; Jemec GB
Clin Exp Dermatol; 2010 Jan; 35(1):36-40. PubMed ID: 19549239
[TBL] [Abstract][Full Text] [Related]
8. Topical treatments of skin pain: a general review with a focus on hidradenitis suppurativa with topical agents.
Scheinfeld N
Dermatol Online J; 2014 Jul; 20(7):. PubMed ID: 25046456
[TBL] [Abstract][Full Text] [Related]
9. Hidradenitis suppurativa: A practical review of possible medical treatments based on over 350 hidradenitis patients.
Scheinfeld N
Dermatol Online J; 2013 Apr; 19(4):1. PubMed ID: 24021361
[TBL] [Abstract][Full Text] [Related]
10. Pain management in hidradenitis suppurativa and a proposed treatment algorithm.
Savage KT; Singh V; Patel ZS; Yannuzzi CA; McKenzie-Brown AM; Lowes MA; Orenstein LAV
J Am Acad Dermatol; 2021 Jul; 85(1):187-199. PubMed ID: 32950543
[TBL] [Abstract][Full Text] [Related]
11. Painful hidradenitis suppurativa.
Smith HS; Chao JD; Teitelbaum J
Clin J Pain; 2010 Jun; 26(5):435-44. PubMed ID: 20473053
[TBL] [Abstract][Full Text] [Related]
12. Evidence-based approach to the treatment of hidradenitis suppurativa/acne inversa, based on the European guidelines for hidradenitis suppurativa.
Gulliver W; Zouboulis CC; Prens E; Jemec GB; Tzellos T
Rev Endocr Metab Disord; 2016 Sep; 17(3):343-351. PubMed ID: 26831295
[TBL] [Abstract][Full Text] [Related]
13. Adalimumab Treatment in Women With Moderate-to-Severe Hidradenitis Suppurativa from the Placebo-Controlled Portion of a Phase 2, Randomized, Double-Blind Study.
Gottlieb A; Menter A; Armstrong A; Ocampo C; Gu Y; Teixeira HD
J Drugs Dermatol; 2016 Oct; 15(10):1192-1196. PubMed ID: 27741335
[TBL] [Abstract][Full Text] [Related]
14. Emerging drugs for the treatment of hidradenitis suppurativa.
Folkes AS; Hawatmeh FZ; Wong A; Kerdel FA
Expert Opin Emerg Drugs; 2020 Sep; 25(3):201-211. PubMed ID: 32667213
[TBL] [Abstract][Full Text] [Related]
15. Clindamycin as unique antibiotic choice in Hidradenitis Suppurativa.
Rosi E; Pescitelli L; Ricceri F; Di Cesare A; Novelli A; Pimpinelli N; Prignano F
Dermatol Ther; 2019 Mar; 32(2):e12792. PubMed ID: 30515931
[TBL] [Abstract][Full Text] [Related]
16. Long-term results of acitretin therapy for hidradenitis suppurativa. Is acne inversa also a misnomer?
Boer J; Nazary M
Br J Dermatol; 2011 Jan; 164(1):170-5. PubMed ID: 20874789
[TBL] [Abstract][Full Text] [Related]
17. Pain in Hidradenitis Suppurativa: A Pilot Study.
Ring HC; Sørensen H; Miller IM; List EK; Saunte DM; Jemec GB
Acta Derm Venereol; 2016 May; 96(4):554-6. PubMed ID: 26631388
[No Abstract] [Full Text] [Related]
18. Experience with ustekinumab for the treatment of moderate to severe hidradenitis suppurativa.
Gulliver WP; Jemec GB; Baker KA
J Eur Acad Dermatol Venereol; 2012 Jul; 26(7):911-4. PubMed ID: 21605174
[TBL] [Abstract][Full Text] [Related]
19. Scientific evidence for the use of current traditional systemic therapies in patients with hidradenitis suppurativa.
Alhusayen R; Shear NH
J Am Acad Dermatol; 2015 Nov; 73(5 Suppl 1):S42-6. PubMed ID: 26470615
[TBL] [Abstract][Full Text] [Related]
20. Hidradenitis suppurativa: guidelines of the Italian Society of Dermatology and Venereology (SIDeMaST) for the use of anti-TNF-α agents.
Megna M; Bettoli V; Chimenti S; Chiricozzi A; Naldi L; Virgili A; Girolomoni G; Monfrecola G
G Ital Dermatol Venereol; 2015 Dec; 150(6):731-9. PubMed ID: 26513043
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
